GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers

$864,718
James Michael Pierce · University Of Georgia · U01 · FY2010 · CA

PFAS AND OTHER TOXIC MILITARY EXPOSURES AND PANCREATIC CANCER RISK IN A MILITARY POPULATION

$864,533
Metis Foundation · · FY2025 · Defense Health Agency

Biological Functions of Chromosomal Proteins

$864,126
Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Tissue factor-dependent coagulation in thrombosis and immune responses

$863,736
Nigel Mackman · Univ Of North Carolina Chapel Hill · R35 · FY2021 · HL

Mesothelin-targeted immunotoxins in Pancreatic Cancer

$863,617
Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer

$861,010
Ajay Goel · Beckman Research Institute/City Of Hope · U01 · FY2025 · CA

The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders

$860,439
Dean D Metcalfe · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas

$860,394
Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2015 · CA

Protein Structure, Stability, and Amyloid Formation

$858,816
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

MOUSE CANCER MODELS VIA TGF-BETA RII LOSS

$858,135
Vanderbilt University · U01 · FY2001 · CA

Pancreatic Cancer Detection Consortium

$857,987
Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2022 · CA

Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan)

$857,421
Rachael Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms

$857,224
Randall Brand · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · CA

DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs

$856,746
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma

$856,578
Peter Qinhua Huang · Zeno Management, Inc · R44 · FY2019 · CA

SPORE in Pancreatic Cancer

$855,582
Donald J. Buchsbaum · University Of Alabama At Birmingham · P20 · FY2007 · CA

Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis

$855,078
Matthew J. Flick · Univ Of North Carolina Chapel Hill · U01 · FY2020 · HL

Pancreatic Tumor Micro-environment Network

$854,923
Surinder Kumar Batra · University Of Nebraska Medical Center · U54 · FY2013 · CA

Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA

$853,888
Vladimir P Torchilin · Northeastern University · U54 · FY2010 · CA

Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines

$853,223
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection

$851,560
Alexander R. Ivanov · Northeastern University · R01 · FY2019 · CA

PRSS1 Mutation and Pancreatic Cancer Tumorigenesis

$850,552
Baoan Ji · Mayo Clinic Jacksonville · R01 · FY2025 · CA

Mouse Models of Gastrointestinal Cancer

$850,000
University Of Cincinnati · U01 · FY2004 · CA

Prevention &Metastasis: Final Frontiers in Colon Cancer

$850,000
Vanderbilt University · U01 · FY2004 · CA

Drug Development Core

$849,648
Daniel D Von Hoff · Translational Genomics Research Inst · P01 · FY2007 · CA